7 found
Order:
  1.  45
    It’s Time for a Black Bioethics.Keisha Shantel Ray - 2021 - American Journal of Bioethics 21 (2):38-40.
    There are some long-standing social issues that imperil Black Americans’ relationship with health and healthcare. These issues include racial disparities in health outcomes, provider bi...
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   9 citations  
  2.  55
    Not Just “Study Drugs” for the Rich: Stimulants as Moral Tools for Creating Opportunities for Socially Disadvantaged Students.Keisha Shantel Ray - 2016 - American Journal of Bioethics 16 (6):29-38.
    An argument in the cognitive enhancement literature is that using stimulants in populations of healthy but socially disadvantaged individuals mistakenly attributes pathology to nonpathological individuals who experience social inequalities. As the argument goes, using stimulants as cognitive-enhancing drugs to solve the social problem of poorly educated students in inadequate schools misattributes the problem as an individual medical problem, when it is really a collective sociopolitical problem. I challenge this argument on the grounds that not all types of enhancement have to (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   21 citations  
  3.  13
    When People of Color Are Left out of Research, Science and the Public Loses.Keisha Shantel Ray - 2020 - American Journal of Bioethics Neuroscience 11 (4):238-240.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  4.  34
    Intersectionality and Power Imbalances Clinicians of Color Face When Patients Request White Clinicians.Keisha Shantel Ray - 2019 - American Journal of Bioethics 19 (2):25-26.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  5. Motivation's Pick-Me-Upper: Enhancing Performance Through Motivation-Enhancing Drugs.Keisha Shantel Ray - 2015 - American Journal of Bioethics Neuroscience 6 (1):50-51.
    Torben Kjærsgaard’s argues that the term “cognitive enhancement substances” is an inappropriate term considering that stimulants do not enhance cognition, but rather only enhance motivation. Therefore, he concludes that stimulants are best described as “performance maintenance” and not “performance enhancement.” I challenge his conclusion on the grounds that both life’s ordinary, daily activities and life’s extraordinary activities are types of performances necessary for living the kinds of lives that we want to live, which can be enhanced, not just maintained, with (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  6.  24
    Response to Open Peer Commentaries on “Not Just ‘Study Drugs’ for The Rich: Stimulants as Moral Tools for Creating Opportunities for Socially Disadvantaged Students”.Keisha Shantel Ray - 2016 - American Journal of Bioethics 16 (6):8-10.
    An argument in the cognitive enhancement literature is that using stimulants in populations of healthy but socially disadvantaged individuals mistakenly attributes pathology to nonpathological individuals who experience social inequalities. As the argument goes, using stimulants as cognitive-enhancing drugs to solve the social problem of poorly educated students in inadequate schools misattributes the problem as an individual medical problem, when it is really a collective sociopolitical problem. I challenge this argument on the grounds that not all types of enhancement have to (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark  
  7.  33
    Review of Jeffrey P. Spike and Rebecca Lunstroth, A Casebook in Interprofessional Ethics: A Succinct Introduction to Ethics for the Health Professions. [REVIEW]Keisha Shantel Ray - 2017 - American Journal of Bioethics 17 (3):1-3.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark